TEAS for Gastrectomy Recovery

The goal of this clinical trial is to learn if transcutaneous electrical acupoint stimulation (TEAS) works to help people recover faster after laparoscopic surgery for stomach cancer. TEAS is a treatment that uses small electrical pulses through sticky pads on the skin. It does not use needles. The main questions it aims to answer are: Does TEAS help people pass gas (a sign that the digestive system is waking up) sooner after surgery? Does TEAS help lower pain after surgery? Does TEAS reduce the need for extra pain medication after surgery? Researchers will compare two groups to see if TEAS works better than a sham (inactive) treatment. Group 1 (TA group) receives real TEAS after surgery. Group 2 (SA group) receives a sham treatment at the same time points. All participants will receive the same standard pain relief and recovery care after surgery. Participants will: Be randomly assigned (like flipping a coin) to one of the two groups. Receive TEAS or sham treatment for 30 minutes starting 2 hours after waking from anesthesia, and then once daily each morning on the first 3 days after surgery. Rate their pain on a 0-10 scale at 6, 12, 24, 48, and 72 hours after surgery. Complete quality-of-life and fatigue questionnaires before surgery, on day 4 after surgery, and 30 days after surgery. Have a follow-up visit or phone call 30 days after leaving the hospital. This study includes 104 adults aged 18 to 80 years who are scheduled to have laparoscopic surgery for stomach cancer at 8 hospitals in Shandong Province, China.

Inclusion Criteria: * Age 18 to 80 years, both sexes * Endoscopically and radiographically confirmed resectable stage I-III gastric * cancer (AJCC 8th edition) * Scheduled to undergo laparoscopic radical gastrectomy * Willing to sign the informed consent form and able to comply with all study procedures Exclusion Criteria: * American Society of Anesthesiologists (ASA) physical status ≥ IV * Clinical stage IV gastric cancer * Severe hepatic, renal, cardiovascular, or cerebrovascular diseases, or uncontrolled psychiatric disorders that may affect compliance or safety assessment * Participation in another clinical trial or receipt of any form of acupoint stimulation (acupuncture, electroacupuncture, TEAS, etc.) within 1 month prior to enrollment * Continuous use of opioids for more than 3 months prior to enrollment, with a daily dose ≥ 30 mg oral morphine equivalent * Implanted cardiac pacemaker or other electronic stimulation device, or skin infection/lesion at the stimulation site * Pregnancy or lactation * Emergency surgery due to bleeding, perforation, obstruction, etc. * Planned epidural anesthesia for the surgery